Glazer Capital’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-437,864
Closed -$9.5M – 102
2017
Q2
$9.5M Buy
+437,864
New +$7.95M 0.61% 35

Other funds holding AMRI

Glazer Capital's AMRI Position: Q3 2017 in Review

Glazer Capital sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 437,864 shares — an estimated $9.5M sold.

Glazer Capital first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $9.5M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Glazer Capital reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Glazer Capital sold 437,864 Albany Molecular Research Inc shares in Q3 2017, an estimated $9.5M.
  • Glazer Capital first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Glazer Capital's Albany Molecular Research Inc position peaked at $9.5M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Glazer Capital's 13F filing for Q3 2017, filed 14 Nov 2017.